7 Articles
7 Articles
/PRNewswire/ -- Field Medical, Inc., a clinical-stage company redefining cardiac ablation with pulsed field ablation (PFA) technology...
Field Medical raises $35m to advance ablation system development
Field Medical has closed a $35m series B financing round for advancing the development of the FieldForce Pulsed Field Ablation platform.The post Field Medical raises $35m to advance ablation system development appeared first on Medical Device Network.
Field Medical closes a $35 million overfunded Series B to fuel development of the FieldForce™ pulsed field ablation platform
Field Medical Closes Oversubscribed $35 Million Series B To Advance Development Of FieldForce™ Pulsed Field Ablation Platform - Medical Device News Magazine
The Series B financing will support the initiation of the company's pivotal VERITAS trial, advance the FieldForce Ablation System development, and further expand Field Medical's clinical and regulatory capabilities.
Field Medical Closes Oversubscribed $35 Million Series B to Advance Development of FieldForce™ Pulsed Field Ablation Platform
BioStar Capital and Cue Growth co-lead financing to accelerate pivotal trial readiness and expand the ventricular tachycardia (VT) treatment marketNew board leadership reflects Field's momentum and readiness for pivotal execution
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium